[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-NGEN":3,"homepage-market-summary":29,"stock-news-NGEN":172},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":14},"NGEN","2026-10-06",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":9,"founded":9,"is_fund":13,"issuer":9,"category":9},"NervGen Pharma Corp. Common stock","Nasdaq",null,"Common Stock","NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions. The Company's principal business activity is the discovery, development and commercialization of neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions. NervGen's initial target indication is SCI. The company's pipeline products include NVG-291 and NVG-300.","9",false,{"close":15,"open":16,"high":17,"low":18,"prev_close":16,"change":19,"percent_change":20,"volume":21,"transactions":22,"vwap":23,"high_52w":24,"low_52w":25,"avg_volume_52w":26,"range_52w_percent":27,"record_count":28},1.75,1.81,1.82,1.73,-0.06,-3.31,297250.891699,1817,1.781,6.3,1.58,418501.7047771992,3.6,1888,{"status":30,"indices":31,"watchlist":75,"sectors":97,"benchmarks":153},"success",[32,40,47,54,61,68],{"symbol":33,"name":34,"price":35,"change":36,"pct_change":37,"is_up":38,"sparkline":39,"date":5},"SPX","S&P 500",7818.93,44.98,0.58,true,"0.0,11.6 2.3,13.9 4.6,10.5 6.9,12.4 9.3,14.2 11.6,16.0 13.9,11.5 16.2,10.8 18.5,4.8 20.8,4.8 23.2,7.9 25.5,8.0 27.8,6.0 30.1,9.1 32.4,9.8 34.7,10.8 37.1,10.0 39.4,7.0 41.7,4.4 44.0,2.0",{"symbol":41,"name":42,"price":43,"change":44,"pct_change":45,"is_up":38,"sparkline":46,"date":5},"NDX","NASDAQ 100",31224.47,148.03,0.48,"0.0,13.0 2.3,15.0 4.6,13.4 6.9,14.8 9.3,16.0 11.6,16.0 13.9,12.9 16.2,11.7 18.5,6.5 20.8,5.0 23.2,6.6 25.5,6.6 27.8,5.8 30.1,7.8 32.4,7.4 34.7,7.0 37.1,6.4 39.4,4.6 41.7,2.9 44.0,2.0",{"symbol":48,"name":49,"price":50,"change":51,"pct_change":52,"is_up":38,"sparkline":53,"date":5},"DJI","DOW JONES",51521,253,0.49,"0.0,3.6 2.3,6.3 4.6,2.0 6.9,3.3 9.3,6.0 11.6,11.3 13.9,8.7 16.2,9.5 18.5,6.4 20.8,8.0 23.2,10.9 25.5,12.3 27.8,8.2 30.1,11.2 32.4,12.3 34.7,16.0 37.1,15.8 39.4,13.7 41.7,13.0 44.0,10.8",{"symbol":55,"name":56,"price":57,"change":58,"pct_change":59,"is_up":38,"sparkline":60,"date":5},"COMP","NASDAQ Composite",27599.79,122.48,0.45,"0.0,13.6 2.3,15.1 4.6,12.9 6.9,14.2 9.3,16.0 11.6,16.0 13.9,12.2 16.2,11.3 18.5,6.1 20.8,5.1 23.2,7.7 25.5,7.7 27.8,6.6 30.1,8.7 32.4,8.9 34.7,8.4 37.1,8.3 39.4,5.5 41.7,3.1 44.0,2.0",{"symbol":62,"name":63,"price":64,"change":65,"pct_change":66,"is_up":13,"sparkline":67,"date":5},"RUT","RUSSELL 2000",2813.4,-20.4,-0.72,"0.0,2.0 2.3,5.2 4.6,3.9 6.9,5.8 9.3,8.0 11.6,9.4 13.9,7.7 16.2,9.2 18.5,7.6 20.8,5.8 23.2,11.6 25.5,11.9 27.8,11.5 30.1,13.7 32.4,14.8 34.7,16.0 37.1,14.8 39.4,12.0 41.7,10.0 44.0,12.2",{"symbol":69,"name":70,"price":71,"change":72,"pct_change":73,"is_up":13,"sparkline":74,"date":5},"VIX","CBOE VIX",15.01,-0.51,-3.29,"0.0,7.3 2.3,2.0 4.6,9.7 6.9,4.9 9.3,4.5 11.6,2.5 13.9,11.3 16.2,13.7 18.5,13.5 20.8,16.0 23.2,12.3 25.5,10.4 27.8,13.5 30.1,8.8 32.4,8.9 34.7,7.8 37.1,7.6 39.4,11.8 41.7,10.9 44.0,12.9",[76,83,90],{"symbol":77,"name":78,"price":79,"change":80,"pct_change":81,"is_up":38,"sparkline":82,"date":5},"NVDA","NVIDIA Corp",239.24,0.34,0.14,"0.0,14.1 7.3,16.0 14.7,14.6 22.0,11.8 29.3,8.2 36.7,2.4 44.0,2.0",{"symbol":84,"name":85,"price":86,"change":87,"pct_change":88,"is_up":38,"sparkline":89,"date":5},"AAPL","Apple Inc",333.63,0.74,0.22,"0.0,2.0 7.3,16.0 14.7,10.4 22.0,14.6 29.3,9.3 36.7,10.6 44.0,9.4",{"symbol":91,"name":92,"price":93,"change":94,"pct_change":95,"is_up":38,"sparkline":96,"date":5},"TSLA","Tesla Inc",380.68,1.95,0.51,"0.0,13.7 7.3,16.0 14.7,15.0 22.0,15.4 29.3,7.1 36.7,3.0 44.0,2.0",[98,103,108,113,118,123,128,133,138,143,148],{"name":99,"etf":100,"change":101,"price":102,"is_up":38},"Technology","XLK",0.53,202,{"name":104,"etf":105,"change":106,"price":107,"is_up":38},"Financials","XLF",0.24,54.01,{"name":109,"etf":110,"change":111,"price":112,"is_up":13},"Healthcare","XLV",-0.17,167.09,{"name":114,"etf":115,"change":116,"price":117,"is_up":38},"Consumer Cycl","XLY",1.2,111.75,{"name":119,"etf":120,"change":121,"price":122,"is_up":38},"Consumer Staples","XLP",0.9,81.77,{"name":124,"etf":125,"change":126,"price":127,"is_up":38},"Energy","XLE",0.47,63.75,{"name":129,"etf":130,"change":131,"price":132,"is_up":38},"Industrials","XLI",0.87,171.58,{"name":134,"etf":135,"change":136,"price":137,"is_up":38},"Materials","XLB",0.46,49.73,{"name":139,"etf":140,"change":141,"price":142,"is_up":38},"Real Estate","XLRE",1.06,41.1,{"name":144,"etf":145,"change":146,"price":147,"is_up":38},"Utilities","XLU",2.98,41.16,{"name":149,"etf":150,"change":151,"price":152,"is_up":38},"Comm Services","XLC",0.04,111.65,[154,159,163,167],{"ticker":155,"name":156,"price":157,"change":158,"is_up":38},"SPY","SPDR S&P 500 ETF",779.09,0.55,{"ticker":160,"name":161,"price":162,"change":136,"is_up":38},"QQQ","Invesco QQQ Trust",759.69,{"ticker":164,"name":165,"price":166,"change":45,"is_up":38},"DIA","SPDR Dow Jones ETF",514.56,{"ticker":168,"name":169,"price":170,"change":171,"is_up":13},"IWM","iShares Russell 2000",281.37,-0.71,{"ticker":4,"count":173,"articles":174},9,[175,181,187,193,199,205,211,217,222],{"title":176,"link":177,"pubDate":178,"description":179,"source":180},"NervGen Pharma (Nasdaq:NGEN) - Stock Analysis - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiigFBVV95cUxPOGFpbkhkcUswUW9WS0d2X3JKUmFQZXhRSGI4ZWllVG41MGVyOU1WVktsTEhnVmNuSnZCd2hvM0NYa0syUGRXd1NIc0tUTC01bVAwdld6d3pZVmVyc0N6dnhKQ0hYaWo4TGFDZWFqODdsSDZyYTZUdHUtLVJwdXJ3VEtQZ3BGSDViY1E?oc=5","Fri, 02 Oct 2026 05:20:41 GMT","NervGen Pharma (Nasdaq:NGEN) - Stock Analysis Simply Wall Street","Simply Wall Street",{"title":182,"link":183,"pubDate":184,"description":185,"source":186},"NervGen Pharma: The Upside Is Large, But Phase 3 Decides Everything (NASDAQ:NGEN) - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipAFBVV95cUxNUl9oQXNGYVd1N0V4TnJxemJkUHMxVTdmeURQaDA2dTFma0M0bnNwQUNuNXpCWTFvQlIwS2VXbGFUZWpxRFVIXzBST2cyQ0RSREhYUC00MUhIdGF2SVplelBBQ3RMSzhDVzVsbk14MnNncmVNNFhld0pBT2lTdGRtNlNlVWpGVDlkSU13QUlBOENMbWxSamFkeXljSVN6N084eTdraA?oc=5","Thu, 01 Oct 2026 21:26:55 GMT","NervGen Pharma: The Upside Is Large, But Phase 3 Decides Everything (NASDAQ:NGEN) Seeking Alpha","Seeking Alpha",{"title":188,"link":189,"pubDate":190,"description":191,"source":192},"NGEN261016C00002500 Interactive Stock Chart | NGEN Oct 2026 2.500 call Stock - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiYEFVX3lxTE9UYmJwOTZxZnJwZ2ZNWm95dVF6aVhuRjBCdmpEU1N3TDQzUDdyV2poVXFNRHZESHkxdHhjaEs5RkhYdUkwaktDT2JZZ2p1RFVhOXZZMzY4aXRJVVhSRkxHRA?oc=5","Fri, 02 Oct 2026 17:35:32 GMT","NGEN261016C00002500 Interactive Stock Chart | NGEN Oct 2026 2.500 call Stock Yahoo Finance","Yahoo Finance",{"title":194,"link":195,"pubDate":196,"description":197,"source":198},"ETFs Investing in NervGen Pharma Corp. Stocks - TradingView","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiY0FVX3lxTE5IUlppZ3hoLVdUb1c1ZVlod3Bma0thQmpta2QxTEJkT2VKVnZheE5qTlBVR1Q5ZVdvb2pCd3NqVmFCam05RGN5NERiOUdqeFpJRVdVUGw5c0hiVlRFR01qQ09oOA?oc=5","Sun, 04 Oct 2026 15:07:58 GMT","ETFs Investing in NervGen Pharma Corp. Stocks TradingView","TradingView",{"title":200,"link":201,"pubDate":202,"description":203,"source":204},"NervGen Pharma Corp. (NASDAQ: NGEN) Share Price, NGEN Stock News, NGEN Share Price & Updates - kalkine.ca","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiUEFVX3lxTE5KZ0MzNzhBVi1tQjFqaXlaeGhkY2VlS2FoMXQxRnZUckJnUFl0MEdKSjZyZExSTkY3RVkxOVVqNFpLVFowdnA4aThuaVVhYVNa?oc=5","Sat, 26 Sep 2026 01:01:53 GMT","NervGen Pharma Corp. (NASDAQ: NGEN) Share Price, NGEN Stock News, NGEN Share Price & Updates kalkine.ca","kalkine.ca",{"title":206,"link":207,"pubDate":208,"description":209,"source":210},"What Does NervGen Pharma's (NASDAQ:NGEN) Latest Move Mean for Penny Stocks Investors? - Kalkine Media","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivgFBVV95cUxPNlBZVndid29naDkwMDlQSVRlSGVnOHZybUVseExHbjVTWmd3NDAzNXV1a2N1YXNySVFhOGhDVlJ6cEZ4dEdZU1dLcWdTcTJZeHRLZW5lLW4yNG5zb2w3QTV0SHRXSkVGR2Y3U0dFdzFNUldzNzEzMGtzVEdxbHJRaTkzeVlnNTBEZlJfQnJMa2FFZnF1WVhmak9QYnBZR0N0ci1zYWtBUjNLWUpqZ0QzVjJ5OVNjS3dOakdzakpn?oc=5","Mon, 28 Sep 2026 12:30:00 GMT","What Does NervGen Pharma's (NASDAQ:NGEN) Latest Move Mean for Penny Stocks Investors? Kalkine Media","Kalkine Media",{"title":212,"link":213,"pubDate":214,"description":215,"source":216},"NervGen Pharma Flags Non-Cash Accounting Errors, Orders Restatement of 2024–2026 Results - TipRanks","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi1gFBVV95cUxNV205aUNOdmdmdVYwSjZZMmdPR2paeV9CT1EtVmI3UGFPS1dvZ01wZlczalZaLXJId0NSZi1BMVlJdGxFdm1yZDBEYUQ3c2ZWcElzT2JwZ0R0SDZDWHJMM1pCQmlmV3FvTGtKYzZaVkhCWUNSSk92YVdRZkcwOVo5VGNTQURlei1sOGM5Y0hwQnBYM1pVcGMyZFJxZE5GNVp2MnBtTUt6T28ybXhMU0VxUl9CamhFX0lxcTg1cXNpTnZQeWY0eTQ4ZmU2b2RYNFh4NjZDRHln?oc=5","Fri, 25 Sep 2026 21:15:20 GMT","NervGen Pharma Flags Non-Cash Accounting Errors, Orders Restatement of 2024–2026 Results TipRanks","TipRanks",{"title":218,"link":219,"pubDate":220,"description":221,"source":216},"NervGen Pharma Appoints KPMG US as New Auditor After Canadian Resignation - TipRanks","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwwFBVV95cUxNUUloek4tYU9ZWWJpY1Y2QkhVUkdKUDlOQ1hMSGdLWWFkS1VrcTJKVFVmN01DaEpndlJWbEUxRkxtdEJQdjg2VHJJNlNuTFJXN1NEMTFTTVQ2SWFZZVV5OWFBekZiNnV4SHhuTUdTM0lTMFFYNVUyQmt0a0ZpUkNqX1dzT3YxUW44NURJOXlFT280bFFkLUgtWVRjOUtDLVhYM1E1cTlLOTVHU2ZnRTRicVM2dXdwLXBUcXpwdnl2dTk4SXc?oc=5","Thu, 24 Sep 2026 13:42:33 GMT","NervGen Pharma Appoints KPMG US as New Auditor After Canadian Resignation TipRanks",{"title":223,"link":224,"pubDate":225,"description":226,"source":216},"Nervgen’s RESTORE Trial Moves Toward Launch: What NVG-291 Could Mean for NGEN Investors - TipRanks","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi0wFBVV95cUxQeUF4UmVxdy02aWJuLVZnWGc2QzlwTW1GOENkMXF4QUtiV0RaOUc3RUQ2YTNxdEpGaVNwNkhSV2xKRjktb2hDdmczX2tMOW9ydDdheGVOX0dNYmFsODI5MXBCNVFLYnVsSWdibGpnM20tSkJNYTlDVXNPcTNmRlgyRERFLTB2MXB4WjA5ZWJjbHIwRURFRkFuaU5QOHFWOThMV3FwMG9WNTVwWExzbjZaSmhtb0xIUlMtc2tsODRIaWliN0RpRzh4UWwzU2JzT2JSTkNj?oc=5","Fri, 25 Sep 2026 16:54:28 GMT","Nervgen’s RESTORE Trial Moves Toward Launch: What NVG-291 Could Mean for NGEN Investors TipRanks"]